Publications
- Farmacotherapy of osteoporosis: calcium, vitamin D, hormonal treatments, selective estrogen receptor modulators and strontium ranelate2009 | First Faculty of Medicine
- Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study2023 | First Faculty of Medicine
- A decrease in serum 1,25(OH)(2)D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF232022 | First Faculty of Medicine, Third Faculty of Medicine
- Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism2022 | First Faculty of Medicine
- Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values2022 | First Faculty of Medicine
- Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing2021 | First Faculty of Medicine, Third Faculty of Medicine
- Efficacy of teriparatide compared with risedronate on FRAX(R)-defined major osteoporotic fractures: results of the VERO clinical trial2020 | First Faculty of Medicine
- S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity2020 | First Faculty of Medicine
- Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial2019 | First Faculty of Medicine
- Glucocorticoids, the skeleton and rheumatoid diseases2019 | First Faculty of Medicine
Loading network view...